Published on Pfizer: the world's largest research-based pharmaceutical company (http://www.pfizer.com)

Home > Partnering > Partnering Highlights > Partnering Highlights

Partnering Highlights

Partnering Highlights

When we think partnerships, we think diverse, bold, and inspired. It's in those partnerships where we can find an innovative medicine that saves a life. Or the licensing deal that broadens access to a critical drug. Or the technology collaboration that brings an experimental medicine to clinical trials faster. Or, even a business process that improves the way we help our customers.

Our partnerships, while individualized in scope and breadth, all offer the possibility of a healthier world. Read about some of our partnerships

Recent Partnerships

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next
June 6, 2013 CytomX and Pfizer Collaborate to Develop and Commercialize Multiple ProbodyTM-Drug Conjugates in Oncology
May 9, 2013 Pfizer And Astrazeneca Enter Into Agreement For Over-The-Counter Nexium
April 29, 2013 Merck and Pfizer Collaborate to Develop New Diabetes Drug
April 3, 2013 BIND Therapeutics Announces Global Collaboration with Pfizer to Develop and Commercialize Multiple Accurins
January 3, 2013 Repligen announces Licensing Agreement with Pfizer for Spinal Muscular Atrophy Program
January 3, 2013 Philogen S.p.A., a privately held clinical-stage biopharmaceutical company, today announced that it has entered into a strategic worldwide license agreement with Pfizer for Dekavil, a novel investigational therapy for autoimmune diseases
Printable Version
 
 

Submit Your Opportunity

callout-placeholder

Send us your innovative ideas today.

  • Get started now

Source URL: http://www.pfizer.com/partnering/partnership_highlights